Liquid biopsy: emergence of a new era in personalized cancer care
Appl. cancer res
;
38: 1-17, jan. 30, 2018. tab, ilus
Artículo
en Inglés
| LILACS, Inca
| ID: biblio-910469
ABSTRACT
The most successful treatment for cancer involves identifying druggable, biological markers for targeted therapy. In the clinical setting, surgical removal of tumors is the only procedure for identifying such targetable molecules. Shed from tumor cells, these markers are also present in circulating blood, albeit in very negligible amounts. Liquid biopsy is a procedure performed on a blood sample to look for such circulating cancer markers cells or pieces of nucleic acid from the tumor. The procedure shows promise in revolutionizing personalized cancer treatments. Here we briefly review the technique, characterization, and its utilization in clinics
Texto completo:
Disponible
Índice:
LILACS (Américas)
Asunto principal:
Biomarcadores
/
Terapia Molecular Dirigida
/
Ácidos Nucleicos Libres de Células
/
Biopsia Líquida
/
Células Neoplásicas Circulantes
Límite:
Humanos
Idioma:
Inglés
Revista:
Appl. cancer res
Asunto de la revista:
Neoplasmas
Año:
2018
Tipo del documento:
Artículo
País de afiliación:
India
Institución/País de afiliación:
All India Institute of Medical Sciences/BR
/
All India Institute of Medical Sciences/IN
Similares
MEDLINE
...
LILACS
LIS